HCWB
HCW Biologics Inc.
There isn't enough reported data to score HCWB yet.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
HCWB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
HCWB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
HCWB PE Valuation
HCWB has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
HCWB Forward outlook
There aren't enough analyst estimates for HCWB to show an outlook.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
HCWB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2025 | -$148.80 | +$33.60 |
| Q4 2024 | -$184.80 | -$16.80 |
| Q3 2024 | -$240.00 | -$108.00 |
| Q2 2024 | -$249.60 | -$124.80 |
| Q1 2024 | -$182.40 | -$62.40 |
| Q4 2023 | -$168.00 | -$67.20 |
HCWB has the stronger earnings trend. Trailing diluted EPS is down 182% for HCWB versus HIMS down 257%.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
HCWB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $121.7K | +1758% |
| Q1 2026 | $6.5M | +128232% |
| Q4 2025 | $27K | -93% |
| Q3 2025 | $15.6K | -96% |
| Q2 2025 | $6.6K | -99% |
| Q1 2025 | $5.1K | -100% |
| Q4 2024 | $394.8K | -70% |
| Q3 2024 | $426.4K | -50% |
HCWB's revenue is growing: $121,730 last quarter, up 1758% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2601% | +50286 points |
| Q1 2026 | 50% | +38861 points |
| Q4 2025 | -16519% | -15719 points |
| Q3 2025 | -21095% | -20230 points |
| Q2 2025 | -52887% | -50441 points |
| Q1 2025 | -38811% | -38146 points |
| Q4 2024 | -800% | +13 points |
| Q3 2024 | -865% | -270 points |
HCWB's operating margin was −2601% last quarter, up 50286 points from the same quarter a year ago.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over HCWB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over HCWB on profitability, with a higher operating margin.
HCWB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$4M | -$683.8K |
| Q1 2026 | -$1.6M | +$1.9M |
| Q4 2025 | -$3.4M | -$407.2K |
| Q3 2025 | -$3.2M | -$276.4K |
| Q2 2025 | -$3.3M | +$1.6M |
| Q1 2025 | -$3.5M | +$219.7K |
| Q4 2024 | -$2.9M | +$4.7M |
| Q3 2024 | -$3M | +$3.3M |
HCWB has burned cash in almost every quarter: −$12M over the past year, against −$13M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over HCWB on cash generation, producing positive trailing cash flow while its opponent burns cash.
HCWB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +280% | +978K shares |
| 1 year | +613% | +1.1M shares |
| 3 years | +788% | +1.2M shares |
| 5 years | +1014% | +1.2M shares |
HCWB has 1M diluted shares, up 613% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over HCWB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
HCWB Net Leverage
HCWB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
HCWB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.8 | Neutral |
| Stochastic | 0.6 | Oversold |
HCWB's weekly RSI is 37 (neutral) and its Stochastic is 1 (oversold).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
HCWB PE vs Healthcare Sector
HCWB has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
HCWB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.32 | 39% below |
| 20 week MA | $2.39 | 67% below |
| 50 week MA | $4.72 | 83% below |
| 100 week MA | $26.6 | 97% below |
| 200 week MA | $171.4 | 100% below |
HCWB is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
HCWB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $1,245.6 | $600.0 | -52% |
| 2022 | $600.0 | $472.8 | -21% |
| 2023 | $472.8 | $295.2 | -38% |
| 2024 | $295.2 | $100.8 | -66% |
| 2025 | $100.8 | $8.52 | -92% |
| 2026 YTD | $8.52 | $0.80 | -91% |
HCWB has finished every year since 2021 lower, and it's down 91% so far in 2026.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over HCWB on returns for 2026, with the stronger performance.